These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8085558

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN, Atkinson BF, Balsara GR, Hernandez E, Jhala NC.
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study.
    Zaino RJ, Davis AT, Ohlsson-Wilhelm BM, Brunetto VL.
    Int J Gynecol Pathol; 1998 Oct; 17(4):312-9. PubMed ID: 9785131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
    Konski AA, Domenico D, Irving D, Tyrkus M, Neisler J, Phibbs G, Mah J, Eggleston W.
    Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Flow cytometric analysis of endometrial stromal sarcoma.
    Hitchcock CL, Norris HJ.
    Am J Clin Pathol; 1992 Feb; 97(2):267-71. PubMed ID: 1546695
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
    Harlow SP, Eriksen BL, Poggensee L, Chmiel JS, Scarpelli DG, Murad T, Bauer KD.
    Cancer Res; 1991 May 01; 51(9):2403-9. PubMed ID: 2015602
    [Abstract] [Full Text] [Related]

  • 17. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
    Jacobsen M, Jakobsen A, Nedergaard L, Andersen JE, Nielsen K.
    Pathol Res Pract; 1997 May 01; 193(4):283-90. PubMed ID: 9258954
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
    Terada K, Mattson D, Goo D, Shimizu D.
    Gynecol Oncol; 2004 Dec 01; 95(3):483-7. PubMed ID: 15581950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.